Tissue microarrays, tread carefully

Laboratory Investigation

Volumn 84, Issue 12, 2004, Pages 1677-

  Chiriboga, Luis ^a   Osman, Iman ^a   Mikhail, Maryann ^a   Lau, Christie ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANTIGENICITY; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LETTER; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; FEMALE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN ARRAY ANALYSIS; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 10044251350     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700172     Document Type: Letter

References (3)

1. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-1949.
2. DiVito KA, Charette LA, Rimm DL, et al. Long-term preservation of antigenicity on tissue microarrays. Lab Invest 2004;84:1071-1078.
3. Kazan C, Melzer K, Panageas KS, et al. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma. Cancer 2002;95:634-640.